✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Halozyme Therapeutics Inc

Common Name
Halozyme Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
423
Ticker
HALO
Exchange
NASDAQ/NGS
Description
Halozyme Therapeutics Inc. is a biopharmaceutical company that researches, develops, and commercializes proprietary enzymes and drug delivery technologies. Its core platform centers on the patented re...

Halozyme Therapeutics's Energy Data Preview

In 2025, Halozyme Therapeutics disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.

Halozyme Therapeutics disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.

Metric (GJ)2025
Total Energy Consumption
15,147a
Non-Renewable Energy Consumption
8,331a
Renewable Energy Consumption
6,816a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Halozyme Therapeutics’s Energy Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Halozyme Therapeutics's ESG Data Spreadsheet 2025

Insights into Halozyme Therapeutics's Energy Renewability

In 2025, Halozyme Therapeutics consumed a total of 15,146.91 Gigajoules of energy across its operations. Of this total, 45% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 55% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.a

Halozyme Therapeutics's Energy Renewability Rate

45%

How much of Halozyme Therapeutics's energy consumed is renewable?

In 2025, Halozyme Therapeutics consumed a total of 15,146.91 Gigajoules of energy, of which 45% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.a

This moderate level of renewable energy adoption indicates that Halozyme Therapeutics is transitioning toward cleaner energy sources, though a significant share of its energy mix still relies on non-renewable inputs.

Want Full Access to Halozyme Therapeutics's Energy Dataset?
Start 30-Day Free Trial